Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Diagnosis of Kawasaki disease (KD) is occasionally delayed because it is solely based on clinical symptoms. Previous studies have attempted to identify diagnostic biomarkers for KD. Recently, patients with KD were reported to have elevated serum ferritin levels. We investigated the usefulness of the serum ferritin level as a diagnostic biomarker for distinguishing KD from other acute febrile illnesses. Blood samples were obtained from pediatric patients with KD (N=77) and those with other acute febrile illnesses (N=32) between December 2007 and June 2011 for measuring various laboratory parameters, including serum ferritin levels. In patients with KD, laboratory tests were performed at diagnosis and repeated at 2, 14, and 56 days after intravenous immunoglobulin treatment. At the time of diagnosis, serum ferritin levels in patients with KD (188.8 μg/L) were significantly higher than those in patients with other acute febrile illnesses (106.8 μg/L, P=0.003). The serum ferritin cut-off value of 120.8 μg/L effectively distinguished patients with KD from those with other acute febrile illnesses, with a sensitivity and specificity of 74.5% and 83.3%, respectively. Serum ferritin may be a useful biomarker to distinguish KD from other acute febrile illnesses.
Abstract
Diagnosis of Kawasaki disease (KD) is occasionally delayed because it is solely based on clinical symptoms. Previous studies have attempted to identify diagnostic biomarkers for KD. Recently, patients with KD were reported to have elevated serum ferritin levels. We investigated the usefulness of the serum ferritin level as a diagnostic biomarker for distinguishing KD from other acute febrile illnesses. Blood samples were obtained from pediatric patients with KD (N=77) and those with other acute febrile illnesses (N=32) between December 2007 and June 2011 for measuring various laboratory parameters, including serum ferritin levels. In patients with KD, laboratory tests were performed at diagnosis and repeated at 2, 14, and 56 days after intravenous immunoglobulin treatment. At the time of diagnosis, serum ferritin levels in patients with KD (188.8 μg/L) were significantly higher than those in patients with other acute febrile illnesses (106.8 μg/L, P=0.003). The serum ferritin cut-off value of 120.8 μg/L effectively distinguished patients with KD from those with other acute febrile illnesses, with a sensitivity and specificity of 74.5% and 83.3%, respectively. Serum ferritin may be a useful biomarker to distinguish KD from other acute febrile illnesses.
참고문헌 (20)
- Kawasaki T, "A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan", Pediatrics, 54, pp.271~276 (1974)
- McCrindle BW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association", Circulation, 135, pp.e927~e999 (2017)
- Knovich MA, "Ferritin for the clinician", Blood Rev, 23, pp.95~104 (2009)
- de Godoy MF, "Serum ferritin and obstructive coronary artery disease: angiographic correlation", Arq Bras Cardiol, 88, pp.430~433 (2007)
- Salonen JT, "High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men", Circulation, 86, pp.803~811 (1992)
- Takahara T, "Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease", Rheumatol Int, 35, pp.81~84 (2015)
- Yamamoto N, "Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy", Mod Rheumatol, 25, pp.898~902 (2015)
- Mizuta M, "Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease", Mod Rheumatol, 26, pp.929~932 (2016)
- Nasir A, "Very high serum ferritin levels in three newborns with Kawasaki-like illness", Paediatr Child Health, 17, pp.201~204 (2012)
- Ackerman Z, "The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection", J Med Virol, 83, pp.1262~1268 (2011)
- Soepandi PZ, "Clinical course of avian influenza A (H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008", Chest, 138, pp.665~673 (2010)
- Chaiyaratana W, "Serum ferritin levels in children with dengue infection", Southeast Asian J Trop Med Public Health, 39, pp.832~836 (2008)
- Kawamata R, "Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia", J Infect Chemother, 21, pp.783~789 (2015)
- Shin Sunghwan, "Comparison of Three Blood Collection Tubes for 35 Biochemical Analytes: The Becton Dickinson Barricor Tube, Serum Separating Tube, and Plasma Separating Tube", Annals of Laboratory Medicine, 41(1), pp.114~119 (2021), 대한진단검사의학회[DOI]
- Dahdah N, "Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease", Pediatr Cardiol, 30, pp.810~817 (2009)
- 이현주, "가와사끼병에서 진단적 지표로서의 NT-proBNP", Clinical and Experimental Pediatrics, 49(5), pp.539~544 (2006), 대한소아청소년과학회
- 이동원, "불완전 가와사끼병에서 NT-proBNP의 진단적 역할", Clinical and Experimental Pediatrics, 53(4), pp.519~524 (2010), 대한소아청소년과학회
- Guo L, "The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease", Diabetes Technol Ther, 16, pp.224~234 (2014)
- Ohno T, "Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease", Eur J Pediatr, 161, pp.105~111 (2002)
- Cunha BA, "Adult Kawasaki’s disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels", Heart Lung, 39, pp.164~172 (2010)